Clinical trial

Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

NCT01918761

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2013-07-30

PhasePHASE1

Study timeline

Study start (unknown)2013-07-30Date precision: day

Registry last updated2019-12-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

Dacomitinib, PemetrexedDRUG

Sponsors & collaborators

Central European Cooperative Oncology Grouplead sponsor

Mapped research locations

GrazAustria1 InnsbruckAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01918761 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.